Resources

Type of publications
Regions
Diseases

5255 results found

2022 ∙ Keshavarz, P. Yazdanpanah, F. Emad, M. Hajati, A. Nejati, S. F. Ebrahimian Sadabad, F. Azrumelashvili, T. Mizandari, M. Raman, S. S.

Myocarditis Following COVID-19 Vaccination: Cardiac Imaging Findings in 118 Studies

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Voleti, N. Reddy, S. P. Ssentongo, P.

Myocarditis in SARS-CoV-2 infection vs. COVID-19 vaccination: A systematic review and meta-analysis

  • Children
  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Li, M. Wang, X. Feng, J. Feng, Z. Li, W. Ya, B.

Myocarditis or Pericarditis Following the COVID-19 Vaccination in Adolescents: A Systematic Review

  • Adolescents
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Goyal, M. Ray, I. Mascarenhas, D. Kunal, S. Sachdeva, R. A. Ish, P.

Myocarditis post-SARS-CoV-2 vaccination: A systematic review

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Yasuhara, J. Masuda, K. Aikawa, T. Shirasu, T. Takagi, H. Lee, S. Kuno, T.

Myopericarditis After COVID-19 mRNA Vaccination Among Adolescents and Young Adults: A Systematic Review and Meta-analysis

  • Adolescents
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Ling, Ryan Ruiyang Ramanathan, Kollengode Tan, Felicia Liying Tai, Bee Choo Somani, Jyoti Fisher, Dale MacLaren, Graeme

Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Pittet, L. F. Thøstesen, L. M. Aaby, P. Kofoed, P. E. Curtis, N. Benn, C. S.

Neonatal Bacillus Calmette-Guérin Vaccination to Prevent Early-Life Eczema: A Systematic Review and Meta-analysis

  • Newborn
  • Tuberculosis
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Cancarevic, I. Nassar, M. Medina, L. Sanchez, A. Parikh, A. Hosna, A. Devanabanda, B. Vest, M. Ayotunde, F. Ghallab, M. Omran, I.

Nephrotic Syndrome in Adult Patients With COVID-19 Infection or Post COVID-19 Vaccine: A Systematic Review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Lotan, I. Lydston, M. Levy, M.

Neuro-Ophthalmological Complications of the COVID-19 Vaccines: A Systematic Review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Alonso Castillo, R. Martínez Castrillo, J. C.

Neurological manifestations associated with COVID-19 vaccine

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...